LexDanaLexDanabeta
Inventor

Butrus Atrash

Inventor
London, GB

Overview

11→
Patents
1995–2021
Patent span
Human necessities
Primary field (CPC A)

Patents· 11 as inventor

Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.

A61Pprimary
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations35%
C07DHeterocyclic compounds32%
A61KPreparations for medical, dental or toiletry purposes29%
C07KPeptides3%
PatentTitleYear
11,046,688Inhibitor compounds202110,479,788Compounds that inhibit MPS1 kinase201910,188,642Pharmacologically active compounds20199,895,364'Pharmacologically active compounds'20189,890,157'Inhibitor compounds'20189,834,552Inhibitor compounds20179,409,907'Inhibitor compounds'20169,371,319'Pyrrolopyridineamino derivatives as MPS1 inhibitors'20169,334,286'Pharmacologically active compounds'20168,592,581'Trisubstituted purine derivatives'20135,424,291'Isosteric peptides'1995

Career & activity timeline

Assembled from patent assignee/location history and declaration credentials.

1995Based in Chandlers Ford, GB· patent location history
2013–2016Patents assigned to CANCER REC TECH LTD (3)· patent assignee history
2013–2016Patents assigned to ATRASH BUTRUS (2)· patent assignee history
2013–2016Patents assigned to SHELDRAKE PETER WILLIAM (2)· patent assignee history
2013Based in Hants, GB· patent location history
2016Patents assigned to BAVETSIAS VASSILIOS (1)· patent assignee history
2016–2021Based in London, GB· patent location history
2016Based in Sutton, GB· patent location history
2017–2021Patents assigned to CANCER RESEARCH TECH LTD (6)· patent assignee history

Inventor activity

Assignee and location history derived from the patent record.

Assignees
AssigneePatentsSpan
CANCER RESEARCH TECH LTD62017–2021
CANCER REC TECH LTD32013–2016
ATRASH BUTRUSself22013–2016
SHELDRAKE PETER WILLIAM22013–2016
BAVETSIAS VASSILIOS12016
Locations
LocationPatentsSpan
London, GB82016–2021
Sutton, GB12016
Hants, GB12013
Chandlers Ford, GB11995